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The risk of bacteremia is considered low in children with acute bronchiolitis. However the
rate of occult bacteremia in infants with RSV infection is not well established. The aim was
to determine the actual rate and predictive factors of bacteremia in children admitted to hos-
pital due to confirmed RSV acute respiratory illness (ARI), using both conventional culture
and molecular techniques.
Methods
A prospective multicenter study (GENDRES-network) was conducted between 2011–2013
in children under the age of two admitted to hospital because of an ARI. Among those RSV-
positive, bacterial presence in blood was assessed using PCR forMeningococcus, Strep-
tococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Klebsiella
pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, in
addition to conventional cultures.
Results
66 children with positive RSV respiratory illness were included. In 10.6% patients, bacterial
presence was detected: H. influenzae (n = 4) and S. pneumoniae (n = 2). In those patients
with bacteremia, there was a previous suspicion of bacterial superinfection and had
received empirical antibiotic treatment 6 out of 7 (85.7%) patients. There were significant dif-
ferences in terms of severity between children with positive bacterial PCR and those with
negative results: PICU admission (100% vs. 50%, P-value = 0.015); respiratory support
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necessity (100% vs. 18.6%, P-value < 0.001); Wood-Downes score (mean = 8.7 vs. 4.8
points, P-value < 0.001); GENVIP scale (mean = 17 vs. 10.1, P-value < 0.001); and length
of hospitalization (mean = 12.1 vs. 7.5 days, P-value = 0.007).
Conclusion
Bacteremia is not frequent in infants hospitalized with RSV respiratory infection, however, it
should be considered in the most severe cases.
Introduction
Respiratory syncytial virus (RSV) is the main cause of viral acute respiratory infection and
leads to hospitalization in infants and young children worldwide, being responsible for 60% to
80% of hospitalizations for bronchiolitis [1]. The main complication of viral respiratory infec-
tions is bacterial co-infection and respiratory failure. The synergism between virus and bacteria
has been widely discussed in the literature, particularly for respiratory viruses and secondary
bacterial pneumonia [2]. Bacteremia rates reported in children with respiratory illness are low,
with rates<1.2% in RSV—confirmed cases [3–7]. In those requiring mechanical ventilation,
bacterial co-infection rates in respiratory samples are consistently higher but may vary, ranging
from 21.0% to 43.9% [8,9]. However, the prevalence, clinical phenotype and course of bacter-
emia with pathogenic bacteria in the setting of acute RSV infection in infants with no other
risk factors, are questions that have not been investigated in sufficient detail, even less with the
use of molecular diagnostics.
The aim of this study was to determine the actual rate and predictive factors of bacteremia
in children admitted to hospital due to confirmed RSV acute respiratory illness using both con-
ventional culture and molecular techniques.
Materials and Methods
Study design and recruitment criteria
This is an observational prospective sub-study performed from January 2011 to January 2013,
in the framework of GENDRES (Genetic, Vitamin D and Respiratory Infections Research Net-
work– www.gendres.org), a research network on pediatric acute respiratory infections that
includes 13 Spanish tertiary hospitals. For this study, previously healthy infants under the age
of two admitted to any of the participant hospitals in the GENDRES network with confirmed
RSV infection were included. Patients with a history of known immunodeficiency, severe car-
diac anomaly, severe chronic lung disease, neuromuscular disease, chromosomal abnormalities
or any ongoing chronic disease were excluded from the study. A complete clinical record, a
blood sample and a nasopharyngeal sample were collected in all included participants.
The severity of each respiratory episode was ranked as follows: 1) physician criteria (mild,
moderate or severe); 2) Wood-Downes scale (0 to 10 points; mild< 3, moderate 4–7,
severe> 8); and 3) a newly developed scale -named GENVIP score- (0 to 20 points) that
assesses food tolerance, degree of medical intervention needed, respiratory distress, respiratory
frequency, apnea, malaise and fever (article in preparation; data in S1 Table [10]).
The study was performed according to Good Epidemiological Practice and written informed
consent was obtained from a parent or legal guardian for each subject before study inclusion.
The study was approved by the Ethics Committee of Clinical Investigation of Galicia (CEIC ref
2010/015).
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Clinical data collection and laboratory methods
The patients’ clinical and demographic data were collected using a secure web-based platform.
RSV status was determined both by conventional methods/rapid test in the referring hospital,
and by molecular techniques in nasopharyngeal secretions. For RSV assessment by molecular
techniques, a nasopharyngeal sample was obtained for the study during hospitalization, using
either a sterile feeding tube and injector for nasopharyngeal aspirate/wash, or a sterile nylon
swab (FLOQSwabsTM by Copan Diagnostics, Brescia, Italy), without culture medium. A panel
of 19 viruses including RSV was sought by nested polymerase chain reaction (PCR). Methods
were previously described in Cebey-López et al. [11].
A peripheral blood sample for analysis was also collected from each patient at the same time
as the swab, in an EDTA BD Vacutainer1 K3E 5.4 mg tube (Becton Dickinson, Franklin
Lakes, Plymouth, UK). In some patients, the initial conventional bacterial test was performed
on hospital admission samples, whilst PCR was performed using samples obtained after the
patients were transferred to PICU and recruited into the study. PCR results were not shared
with clinicians due to all PCR were performed simultaneously off-patient. Blood samples were
pretreated as follows: 250ul of blood was mixed with 25ul lysozyme (100 mg/ml, Sigma-
Aldrich, St Louis, Missouri, USA) and 10ul lysostaphin (1mg/ml, Sigma-Aldrich, St Louis, Mis-
souri, USA), vortexed briefly and incubated at 37°C for 30 minutes. 0.1g lysing matrix B beads
(MP Biomedicals, Santa Ana, California, USA) were added and the mixture was agitated at
30Hz for 2x30s using a TissueLyser II (Qiagen, Hilden, Germany). 200ul lysis buffer AL (Qia-
gen, Hilden, Germany) was added and the samples were centrifuged at 5,500 rpm for 2 minutes
to pellet the lysis beads. 200ul of the lysed blood sample was then transferred onto a Biorobot
MDx (Qiagen, Hilden, Germany) and total nucleic acid extracted using silica membrane chem-
istry and eluted in 200ul of elution buffer AE (QIAamp DNA Blood Biorobot MDx extraction
kit, Qiagen, Hilden, Germany).
Nested PCR was then performed to detect the presence of ten different organisms, as below
(Table 1).
The PCRs were performed as two screens, with the first round reactions multiplexed for tar-
gets 1–5 and 6–10 respectively. All first round reactions were performed in 50ul reaction vol-
umes consisting of 20ul template (nucleic acid extracted from blood as described above) and
30ul mastermix (MyTaqHS, Bioline Reagents, London, UK) with each primer added to a final
reaction concentration of 0.2uM. Thermal cycling conditions for the first round reactions
were: 95°C for 2 minutes followed by 30 cycles of 95°C for 15s, 55°C for 15s, 72°C for 15s; this
was performed using a TRIO block thermocycler (Biometra Gmbh, Göttingen, Germany). 1ul
Table 1. Target genes and organisms detected by nested PCR.
Organism Target gene Amplicon size (bp)
Neisseria meningitides porA 947
Streptococcus pneumoniae ply 209
Haemophilus influenzae P6OMP 353
Group A Streptococcus mf 419
Group B Streptococcus cfb 154
Acinobacter baumanii gltA 155
Klebsiella pneumoniae mdh 193
Pseudomonas aeruginosa oprL 163
Escherichia coli phoA 196
Staphylococcus aureus femA 95
doi:10.1371/journal.pone.0146599.t001
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of first round template was transferred into 24ul of second round mastermix (MyTaqHS mas-
termix, Bioline Reagents, London, UK) containing second round primers at a final reaction
concentration of 0.2uM for each primer and 1ul of Evagreen (Biotium, Hayward, California,
USA) per reaction. Second round reactions were performed on a Lightcycler 480 (Hoffman-La
Roche, Basel, Switzerland) using the following cycling conditions: 95°C for 2 minutes followed
by 30 cycles of 95°C for 20s, 55°C for 20s, 76°C for 20s with fluorescence acquisition at 76°C.
This was followed by a melt curve in which fluorescence was acquired from 75–95°C and melt
curve analysis used to detect specific amplification.
DNA extraction and PCR amplification of bacterial targets was performed by a commercial
referral laboratory, Micropathology Ltd (MCP). MCP is accredited by Clinical Pathology
Accreditation (UK) Ltd (CPA, a subsidiary of UKAS) to provide diagnostic pathology services
in the UK. All molecular PCR assays are validated to CPA standards. This process includes
primer specificity checking by an in-house method based on analysis of publically available
sequence data to ensure that observed variation within each species is accounted for and that
no cross-reactivity to other targets can be identified. The sensitivity of the PCRs for all ten tar-
gets is<5 gene copies/reaction. This was derived using a combination of quantitated PCR con-
trol material (AmpliRun, Vircell, Granada, Spain) and synthetic copies of the target amplicon,
quantitated using an automated electrophoresis platform (MultiNA, Shimadzu, Kyoto, Japan).
Bacteremia was defined as the positivity of PCR and/or blood culture. Bacterial superinfec-
tion diagnosis relied on the discretion of the recruiting physician according to clinical data,
inflammatory markers, radiological findings and/or appropriate cultures. PCR was done after
children discharge so results were not shared with clinicians. All PCR were performed simulta-
neously off-patient. Respiratory support was considered as either invasive (mechanical ventila-
tion) or non-invasive ventilation (CPAP, BiPAP). The severity of each respiratory episode was
ranked by physician criteria (mild, moderate or severe). The respiratory distress was rated in
the worst moment of the illness. Spanish national immunization program includes Hib vaccine
but not pneumococcal conjugate vaccine. However average vaccination coverage with pneu-
mococcal conjuagate vaccine is estimated to be 60–65% through the private market.
Data analysis
We performed all the analyses using R Software, version 3.0.2 (http://www.r-project.org). Gen-
eral data are presented as percentages or means with 95% confidence intervals. Different statis-
tical tests were used to assess the association between the variables: Fisher’s exact test for
discrete variables and Wilcoxon test for continuous variables.
Results
Out of 130 eligible patients, 66 were RSV positive (data in S1 Fig). 92.4% of these (n = 61) were
<12 months of age and the majority (66.7%) of the patients were boys. All children were cor-
rectly vaccinated according to the recommended national immunization schedule. Diagnosis
at discharge was predominantly bronchiolitis 78.8% (n = 54) and pneumonia 6.1% (n = 4)
34.9% (n = 23) of the RSV positive patients had a suspected bacterial superinfection accord-
ing to the referring physician. Molecular assessment revealed bacterial presence in the blood of
seven (10.6%) patients (Table 2). No differences were found between those with negative or
positive PCR in terms of sex distribution, age, family history, vaccination rate, diagnosis or
suspicion of bacterial superinfection. There were significant differences in terms of illness
severity between children with positive bacterial PCR and those with negative results: PICU
admission (100% vs. 50%, P-value = 0.015) and respiratory support necessity (100% vs. 18.6%,
P-value< 0.001). Patients with confirmed bacteremia had a more severe respiratory affection
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than those with no bacteria identified in blood (Table 2). Both the Wood-Downes score and
the GENVIP scale indicated a worse value in the blood PCR positive patients (mean = 8.7
points and 17.0 points, respectively) than in the blood PCR negative patients (mean = 4.8
points and 10.1 points) (P-value< 0.001 for both). Hospitalization was longer for children
with PCR-confirmed bacteremia (mean = 12.1 vs. 7.5 days, P-value = 0.007) (Fig 1).
The pathogen found were H. influenzae (n = 4), S. pneumoniae (n = 1) and both simlta-
neously (n = 2). The cycle thresholds were<20 except for S. pneumoniae in the co-infection
Table 2. Summary of the characteristics of RSV cohort and comparison between those with positive and negative blood PCR for bacteria. General
data are presented as percentages or means with 95% confidence intervals. Different statistical models were used to assess the association between the var-
iables: Fisher’s exact test (1) for discrete variables andWilcoxon test (2) for continuous variables.
Variables Total cohort (n = 66) Negative PCR (n = 59) Positive PCR (n = 7) P-value
Demographics
Sex. Female1 33.3% (22/66) 35.6% (21/59) 14.3% (1/7) 0.409
Age (months)1 1.000
< 12 92.4 (61/66) 91.5 (54/59) 100 (7/7)
12–24 3.0% (2/66) 3.4% (2/59) 0.0% (0/7)
> 24 4.5% (3/66) 5.1% (3/59) 0.0% (0/7)
Family history
Asthma1 30.3% (20/66) 71.2% (42/59) 57.1% (4/7) 0.425
Respiratory conditions1 30.3% (20/66) 28.8% (17/59) 42.9% (3/7) 0.425
Medical history
Premature1 4.8% (3/63) 3.6% (2/56) 14.3% (1/7) 0.302
Pneumococcal vaccine 48.5 (32/66) 52.5% (31/59) 14.3% (1/7) 0.106
Clinical data
Oxygen needed1 80.3% (53/66) 78.0% (46/59) 100.0% (7/7) 0.329
Any kind of respiratory support1 27.3% (18/66) 18.6% (11/59) 100.0% (7/7) <0.001
Diagnosis1 0.739
Bronchiolitis 78.8% (52/66) 76.3% (45/59) 100.0% (7/7)
Pneumonia 6.1% (4/66) 6.8% (4/59) 0.0% (0/7)
Bronchial hyperreactivity 15.2% (10/66) 16.9% (10/59) 0.0% (0/7)
Respiratory distress1 0.001
Mild 22.7% (15/66) 25.4% (15/59) 0.0% (0/7)
Moderate 53.0% (35/66) 57.6% (34/59) 14.3% (1/7)
Severe 21.2% (14/66) 13.6% (8/59) 85.7% (6/7)
PICU admission1 57.1% (28/49) 50.0% (21/42) 100.0% (7/7) 0.015
Fever1 0.733
Low-grade fever (37–38°C) 37.5% (18/48) 36.6% (15/41) 42.9% (3/7)
Fever (> 38°C) 50.0% (24/48) 48.8% (20/41) 57.1% (4/7)
Wood Downes Score (mean-SD)2 5.2 (2.4) 4.8 (2.2) 8.7 (1.1) <0.001
GENVIP scale (mean-SD)2 11.1 (4.1) 10.1 (3.6) 17.0 (1.0) <0.001
Hospital length of stay (mean-SD)2 8.0 (4.8) 7.5 (4.7) 12.1 (4.3) 0.007
Suspected bacterial superinfection1 50.0% (33/66) 45.8% (27/59) 85.7% (6/7) 0.105
Blood culture
Done. Yes1 60.0% (27/45) 55.3% (21/38) 85.7% (6/7) 0.215
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cases, in which the cycle threshold was>25. Only in one of these cases this bacteria had also
been identified by conventional cultures.
In nasopharyngeal samples, more than one virus was detected in 35 out of 66 (53.0%)
patients by molecular techniques. In bacterial PCR positive patients, viral co-infection was
observed in 5 out of 7 (71.4%) subjects (Table 3). 30 patients with viral co-infection and nega-
tive PCR were identified (n = 24 patients with two virus and n = 6 with three virus). No statisti-
cal differences were observed in terms of viral co-infection between positive and negative
bacterial PCR (P-value = 0.433)
Antibiotic administration in patients with suspected bacterial superinfection was recorded
in 50.0% (n = 33) of the RSV-infected patients and in 3.3% (n = 1) of these patients a bacterial
superinfection was confirmed by conventional blood cultures. In the patients with confirmed
bacteremia by PCR, n = 6 patients were treated with antibiotics due to suspected bacterial
superinfection. In these 6 patients, wide spectrum antibiotics were used.
There was no correlation between the patients suspected of superinfection and/or pre-
scribed antibiotic by the referring physician, and those with positive blood PCR results
(Cohen’s kappa coefficient bacterial superinfection-PCR = 0.15). A total of 87.5% of the
patients presented fever:> 38°C in 50% of the included children (24 out of 48), and low-grade
fever in 18 of them (37.5%). Fever frequency in children with bacteremia confirmed by PCR
was similar to that in the rest of the cohort (P-value = 0.733).
Discussion
One out of every ten previously healthy children hospitalized due to RSV had bacteremia, and
these patients experienced a more severe disease. Conversely, half ot the remaining RSV
patients included, received empirical antibiotic therapy despite the bacteremia work-up result
was negative.
The prevalence of bacteremia in children with RSV infection reported in the literature is
low, ranging between 0.6 and 1.1% [3–5,12–14]. Our study found rates of concurrent bacter-
emia ten times higher (10.6%). In the studies cited, only conventional cultures were performed,
Fig 1. Severity parameters for the patients: Wood Downes score, GENVIP score, length of
hospitalization, oxygen, respiratory support, respiratory distress and PICU admission. Patients are
classified as: positive RSV in nasopharyngeal sample, positive RSV with confirmed bacteremia, and positive
RSV and suspected bacterial superinfection.
doi:10.1371/journal.pone.0146599.g001
Table 3. Description of RSV infected patients with positive blood bacterial PCR. Abbreviations: NINV: noninvasive ventilation; INV: invasive ventilation;















1 H. influenzae/ S.
pneumoniae
RSV + Rhinovirus Severe 9 Yes NINV Yes Yes
2 H. influenzae RSV Severe 10 Yes NINV Yes Yes
3 S. pneumoniae RSV + Rhinovirus
+ Bocavirus
Severe 10 Yes INV Yes Yes
4 H. influenzae RSV + Bocavirus Moderate 7 Yes NINV Yes Yes
5 H. influenzae/ S.
pneumoniae
RSV + Bocavirus Severe 8 Yes NINV Yes No
6 H. influenzae RSV + Rhinovirus
+ Coronavirus
Severe 9 Yes INV Yes Yes
7 H. influenzae RSV Severe 8 Yes INV Yes Yes
doi:10.1371/journal.pone.0146599.t003
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whereas molecular methods were applied in our series. RSV has been linked to seasonal
increases in S. pneumoniae disease [15], as well as to other viruses such as influenza, but the
underlying mechanisms between viral and bacterial synergism are complex and remain
unclear. Immunization programs with conjugate vaccines against invasive H. influenzae sero-
type b and Streptococcus pneumoniae have changed the frequency of bacteremia in febrile
infants (10,13). In our series, only 14.3% of the PCR positive patients had been vaccinated
against pneumococcal disease, as compared to PCR negative ones, with 52.5% having received
the vaccine. Animal studies found important mechanism of viral-bacterial synergy between
bovine RSV and Histophilus somni and other bacterial pathogens [16]. This could indicate
that RSV and H.influenzae have the same infection pattern in human patients.
The diagnosis of bacterial superinfection is most often made on clinical grounds, and not
always confirmed microbiologically. Antibiotics should not be administered to RSV-infected
children unless complications such as secondary bacterial illness occur [17,18]. In our series,
blood cultures were not carried out systematically, but only when a bacterial superinfection
was suspected by the referring physician. Blood culture is considered the gold standard for bac-
teria detection, but has a low sensitivity and some bacteria are difficult to culture. Blood PCR–
much more sensitive–was performed in all the recruited patients but the clinical relevance of
its positive result is not clear. Detecting circulating DNA in the blood by PCR has some limita-
tions and it is essential to extrapolate always the results obtained to the clinical grounds to see
if both PCR results and the clinical phenotype are consistent [19]. The quantitative PCR and
the cycle threshold value are inversely correlated with the bacteria load and could be an indica-
tor to avoid false positive results. In our cohort the cycle threshold was<20, but as we only
have seven positive samples we could not establish maximum cutoff levels.
In our series, the physician suspected bacterial superinfection in half of the cases, a propor-
tion similar to that in Thibeault et al.’s study [20]. Even though a blood culture was obtained
for many of our patients (60.0%), only 3.8% (n = 1) yielded a positive result. Furthermore, we
failed to find any correlation between PCR-confirmed bacteremia and clinical suspicion of bac-
terial superinfection (Cohen’s kappa coefficient = 0.15). Therefore, in agreement with other
studies [14,21], we found that children with uncomplicated bacterial RSV infection are often
overtreated with empirical antibiotics.
Empirical antibiotic treatment is often prescribed in practice to children hospitalized due to
a confirmed viral ARI based on fever presence or persistence. Between 23 and 31% of cases of
bronchiolitis are associated with fever [22], and in our series the fever rate (37 and 50%) was in
the range previously described of 45 to 65% for children hospitalized with RSV [23]. However,
the risk of bacteremia is low in febrile children with bronchiolitis [4,6,22], as corroborated in
our series, where fever was not a predictor for bacteremia (P-value = 0.733).
Randolph et al. [9] studied the risk of bacterial infection in children infected with RSV admit-
ted to PICU, and using blood culture they found a rate of bacteremia of only 0.6%. In our study,
the rate of bacteremia found by PCR in children who required PICU admission is higher (25.0%),
probably due to the higher sensitivity of molecular techniques. Bacteremic patients had a more
severe course according to PICU admission rates, respiratory support necessity, clinical scales and
length of hospitalization. Bloomfield et al. [14] suggest that empirical antibiotics should be consid-
ered for any child admitted to PICU with a RSV infection and requiring ventilator. In our series
only half the patients who were admitted to PICU and required ventilatory support had a bacter-
emia revealed by PCR, meaning that antibiotic prescription might be superfluous in up to 50% of
the cases. However, PCR was only performed in blood, meaning that we would be only excluding
systemic bacterial infection, but not all forms of bacterial superinfection. On the other hand, due
to the limited number of bacteremic subjects in our study, further studies are needed to make
robust conclusions with regards to the overuse or underuse of antibiotic therapy.
Bacteremia in RSV Infection
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In conclusion, our data show that concurrent bacteremia is not frequent in infants that are
hospitalized with RSV respiratory infection, even in the presence of fever, and despite the use
of molecular techniques for the diagnosis. However bacteremia may actually occur and it
should be suspected in the more severe cases, although our sample size did not allow us to find
a reliable predictive clinical pattern. Antibiotics are frequently overused in the setting of RSV
infection, and a more judicious approach to prescription should be warranted.
Supporting Information
S1 Fig. Flow chart of the study population.
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